164 related articles for article (PubMed ID: 11477489)
1. Apomorphine to Uprima: the development of a practical erectogenic drug: a personal perspective.
Morales A
Int J Impot Res; 2001 Aug; 13 Suppl 3():S29-34. PubMed ID: 11477489
[TBL] [Abstract][Full Text] [Related]
2. Sublingual apomorphine: new preparation. In erectile disorders: a narrow therapeutic margin.
Prescrire Int; 2002 Jun; 11(59):76-9. PubMed ID: 12068841
[TBL] [Abstract][Full Text] [Related]
3. Oral treatment of erectile dysfunction with apomorphine SL.
Altwein JE; Keuler FU
Urol Int; 2001; 67(4):257-63. PubMed ID: 11741126
[TBL] [Abstract][Full Text] [Related]
4. Apomorphine SL (Uprima): a new treatment for the management of erectile dysfunction.
Wagner G
Int J Impot Res; 2001 Aug; 13 Suppl 3():S1-2. PubMed ID: 11477485
[No Abstract] [Full Text] [Related]
5. Intranasal apomorphine. Nastech Pharmaceutical.
Kendirci M; Hellstrom WJ
IDrugs; 2004 May; 7(5):483-8. PubMed ID: 15154111
[TBL] [Abstract][Full Text] [Related]
6. Characterising the benefit of apomorphine SL (Uprima) as an optimised treatment for representative populations with erectile dysfunction.
Heaton JP
Int J Impot Res; 2001 Aug; 13 Suppl 3():S35-9. PubMed ID: 11477490
[TBL] [Abstract][Full Text] [Related]
7. Sublingual apomorphine for the treatment of erectile dysfunction.
Mulhall JP
Expert Opin Investig Drugs; 2002 Feb; 11(2):295-302. PubMed ID: 11829718
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of apomorphine SL (Uprima).
Bukofzer S; Livesey N
Int J Impot Res; 2001 Aug; 13 Suppl 3():S40-4. PubMed ID: 11477491
[TBL] [Abstract][Full Text] [Related]
9. [Apomorphine and erectile dysfunction].
Tan DQ; Yao Y; Zhang J
Zhonghua Nan Ke Xue; 2007 Sep; 13(9):818-21. PubMed ID: 17929561
[TBL] [Abstract][Full Text] [Related]
10. Commentary on apomorphine versus sildenafil for erectile dysfunction.
Carson CC
J Urol; 2008 May; 179(5 Suppl):S95-6. PubMed ID: 18405768
[No Abstract] [Full Text] [Related]
11. Apomorphine (TAP holdings). 6a beta-aporphine-10,11-diol hydrochloride hemihydrate, apomorphine hydrochloride, spontane, Uprima.
Drugs R D; 1999 Dec; 2(6):415-6. PubMed ID: 10763454
[No Abstract] [Full Text] [Related]
12. Future directions in erectile dysfunction therapy.
Mulhall JP
Postgrad Med; 2000 May; 107(6 Suppl Educational):19-23. PubMed ID: 19667519
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacy of Apomorphine SL in erectile dysfunction of diabetic men.
Gontero P; D'Antonio R; Pretti G; Fontana F; Panella M; Kocjancic E; Allochis G; Frea B
Int J Impot Res; 2005; 17(1):80-5. PubMed ID: 15510184
[TBL] [Abstract][Full Text] [Related]
14. Apomorphine in dopaminergic therapy.
Subramony JA
Mol Pharm; 2006; 3(4):380-5. PubMed ID: 16889431
[TBL] [Abstract][Full Text] [Related]
15. Tolerability and safety of apomorphine SL (Ixense (TM) ).
Montorsi F
Int J Impot Res; 2003 Apr; 15 Suppl 2():S7-9. PubMed ID: 12825097
[TBL] [Abstract][Full Text] [Related]
16. Peripheral modulation of dopaminergic receptors affects erectile responses in rats.
El-Din MM; Senbel AM; Daabees TT; Sharabi FM
Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):225-32. PubMed ID: 17371526
[TBL] [Abstract][Full Text] [Related]
17. Apomorphine SL (Uprima): preclinical and clinical experiences learned from the first central nervous system-acting ED drug.
Giuliano F; Allard J
Int J Impot Res; 2002 Feb; 14 Suppl 1():S53-6. PubMed ID: 11850736
[TBL] [Abstract][Full Text] [Related]
18. Effects of visual sexual stimuli and apomorphine SL on cerebral activity in men with erectile dysfunction.
Hagemann JH; Berding G; Bergh S; Sleep DJ; Knapp WH; Jonas U; Stief CG
Eur Urol; 2003 Apr; 43(4):412-20. PubMed ID: 12667723
[TBL] [Abstract][Full Text] [Related]
19. [Erectile dysfunction].
Lyngdorf P
Ugeskr Laeger; 2002 Oct; 164(41):4779-83. PubMed ID: 12407881
[No Abstract] [Full Text] [Related]
20. [Treatment per os of disorders of erection].
Giuliano F
Prog Urol; 1997 Feb; 7(1):108-9. PubMed ID: 9116726
[No Abstract] [Full Text] [Related]
[Next] [New Search]
